Growth and puberty in thalassemia major.
Present transfusional regimen protocols increase the life expectancy of patients with beta-thalassemia major, but cause a progressive iron overload that can be prevented or limited only by appropriate iron chelation. Siderosis is responsible for the clinical complications of the disease. Short stature and hypogonadism are extremely frequent in patients with thalassemia. Many factors are responsible for short stature in patients with thalassemia, the most important of which are dysfunction of the GH-IGF-I axis and desferoxamine (DFX)-induced bone dysplasia. Hypogonadism is the most frequent endocrine complication, mostly due to gonadotrophins deficiency secondary to iron overload. Sex steroid treatment for induction of puberty and/or maintenance of sexual characteristics is necessary. Both short stature and hypogonadism are present in a significant percentage of bone marrow transplanted patients with thalassemia. Factors responsible for short stature are previous iron overload, liver impairment, DFX treatment, and toxicity of chemotherapeutic agents. In some patients absence of pubertal development is due to gonadotropin insufficiency, probably secondary to previous iron overload; other patients exhibit hypergonadotrophic hypogonadism due to the toxic effect of chemotherapeutic agents on the gonads. Both groups need hormonal replacement therapy. These data support the need for vigilant follow-up of patients with thalassemia before and after transplantation, in order to treat endocrine dysfunctions at the appropriate age.
Raiola
G
G
Auxoendocrinological Unit and Department of Pediatrics, Pugliese Ciaccio Hospital, Catanzaro, Italy. acsa@abramo.it
Galati
M C
MC
De Sanctis
V
V
Caruso Nicoletti
M
M
Pintor
C
C
De Simone
M
M
Arcuri
V M
VM
Anastasi
S
S
D001827:Body Height; D016026:Bone Marrow Transplantation; D015913:Chelation Therapy; D006128:Growth; D006801:Humans; D007006:Hypogonadism / Q000209:etiology; D011627:Puberty; D017086:beta-Thalassemia / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy